Medicine for treating sinus arrhythmia

Abstract

The invention provides a medicine for treating sinus arrhythmia. The medicine consists of the following ingredients in parts by weight: 9 parts of phoenix tree flower, 6 parts of katsumade galangal seeds, 6 parts of semen thlaspi, 3 parts of rhizoma bolbostemmae, 1 part of common clubmoss herb, 1 part of loquat flower, 0.5 part of sappan wood and 0.5 part of bamboo shavings. On the basis, the medicine is further added with 2 parts by weight of mantis egg-case, 2 parts by weight of embryo cervi or 1 part by weight of tender stem and leaf of India mustard. The medicine prescription is obtained on the basis of reasonable design of the traditional Chinese medicinal ingredients; the medicine, on the sinus arrhythmia, is obvious in curative effect and relatively rapid to take effects; and the medicine is better than the prior art in both effective rate and cure rate.

Description

technical field [0001] The invention relates to the field of medical and health technologies, in particular to a medicine for treating sinus arrhythmia. Background technique [0002] A heart rhythm that originates in the sinus node is called sinus rhythm. Sinus rhythm is a normal rhythm. Sinus tachycardia, sinus bradycardia, sinus arrhythmia, sinus arrest, and sick sinus syndrome are sinus arrhythmias. A normal adult sinus rhythm with a frequency >100 beats / min is called sinus tachycardia. The frequency of sinus rhythm is time-divided and is called sinus bradycardia. The origin of sinus rhythm has not changed, but the rhythm is irregular, and the P-P interval difference > 0.12s on the same lead is called sinus arrhythmia, which often coexists with sinus bradycardia. The existing drugs for the treatment of sinus arrhythmia have the technical problems of poor curative effect and slow onset, which greatly limit the therapeutic effect of the disease. Contents of the ...

AI Technical Summary

Problems solved by technology

[0003] The present invention aims at the technical defects of the prior art, and provides a sinus arrhythmia treatment drug to solve the technical problems of poor curative effect and slow onset of the sinus arrhythmia treatment drug in the prior art